Alnylam Pharmaceuticals
ALNY
#630
Rank
HK$314.63 B
Marketcap
HK$2,357
Share price
0.94%
Change (1 day)
11.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company